This inventor holds 1 USPTO granted patent. Top assignees: Changzhou Target Medicine Technology Co., Limited, Suzhou Nanomedicine R&d Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Inventor Xin Che
Introduction
Xin Che is a notable inventor based in Suzhou, China. He has made significant contributions to the field of nanomedicine, particularly through his innovative work on amphiphilic block copolymers. His research focuses on developing drug delivery systems that enhance the efficacy of anti-tumor treatments.
Latest Patents
Xin Che holds a patent for an "Amphiphilic block copolymer and preparation method thereof and micellar drug-loading system formed by same with antitumor drug." This invention relates to a novel amphiphilic block copolymer that comprises a hydrophilic segment and a hydrophobic segment. The end group of the hydrophobic segment is end-capped with a hydrophobic group. The copolymer utilizes methoxypolyethylene glycol (or polyethylene glycol)-polyester block copolymer, which is recognized for its safety. The terminal hydroxyl group of the polyester segment is modified with a hydrophobic group, improving compatibility between the drug molecule and the hydrophobic segments of the block copolymer. This innovation provides a larger space for accommodating drug molecules, resulting in a drug-loaded micelle with high stability.
Career Highlights
Throughout his career, Xin Che has worked with various companies, including Suzhou Nanomedicine R&D Co., Ltd. and Changzhou Target Medicine Technology Co., Limited. His work has been instrumental in advancing the field of drug delivery systems, particularly in the context of cancer treatment.
Collaborations
Xin Che has collaborated with notable colleagues, including Ke Liu and Feirong Gong, who have contributed to his research endeavors.
Conclusion
Xin Che's innovative work in the development of amphiphilic block copolymers represents a significant advancement in nanomedicine. His contributions are paving the way for more effective drug delivery systems in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile